(Q44680424)

English

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Stefania La Grutta

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Pajno GB

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Vita D

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Parmiani S

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Caminiti L

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Barberio G

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1641-1647

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01809.X

21 January 2018

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01809.X

21 January 2018

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01809.X

21 January 2018

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01809.X

21 January 2018

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01809.X

21 January 2018

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2003.01809.X

21 January 2018

Identifiers

10.1111/J.1365-2222.2003.01809.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44680424&oldid=2031621541"